Clinical trials: Attention Disorder With Hyperactivity (ADHD)
Attention Deficit Hyperactivity Disorder
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting
This Phase 3 pivotal efficacy trial will examine the effects of HLD200 (methylphenidate) in patients aged 6-12 years with ADHD in a naturalistic setting.
- Trial name
- NCT02520388
- Testing
- HLD200 methylphenidate hydrochloride (MPH) Capsules
- Where
- 21 sites in United States
- Volunteers
- 163 people
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
Attention Deficit Hyperactivity Disorder
Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children
This study evaluates the efficacy of the Nurtured Heart Approach (NHA) to reduce inattention and hyperactivity and impulsivity in children ages 6 - 8 years.
- Trial name
- NCT03685279
- Testing
- Nurtured Heart Approach
- Where
- United States
- Volunteers
- 104 people, healthy volunteers welcome
- Sponsor
- University of Arizona
Attention Deficit Hyperactivity Disorder (ADHD)
The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this project is to evaluate the effectiveness of a structured aerobic exercise intervention for adults with Attention-Deficit/Hyperactivity Disorder (ADHD) with and without medication and compare it to medication…
- Trial name
- NCT02788851
- Testing
- Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine, Aerobic Exercise
- Where
- Canada
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Attention Deficit Disorder With Hyperactivity
Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder
This study will compare the efficacy and cost effectiveness of two methods of treating adolescents with attention deficit hyperactivity disorder in school.
- Trial name
- NCT00947973
- Testing
- Challenging Horizons Program (CHP) after-school model, Challenging Horizons Program (CHP) consultation model
- Where
- 2 sites in United States
- Volunteers
- 315 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
This study seeks to determine, using special sleep tests (polysomnography and actigraphy) if guanfacine extended release is able to improve nighttime sleep in children with ADHD - associated insomnia while improving daytime ADHD…
- Conditions
- Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder, Insomnia, Sleep Disorders
- Trial name
- NCT01156051
- Testing
- Guanfacine extended-release tablets
- Where
- 2 sites in United States
- Volunteers
- 29 people
- Sponsor
- Children's Specialized Hospital
ADHD, Cognitive Deficit
Cognitive Intervention in Attention Deficit and Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder is a disorder in which children show insufficient attention span, hyperactivity and impulsivity according to their developmental level.
- Trial name
- NCT05063669
- Testing
- Cognitive Occupational Therapy
- Where
- Turkey (Türkiye)
- Volunteers
- 21 people
- Sponsor
- Biruni University
Attention Deficit Disorder With Hyperactivity, Attention Deficit and Disruptive Behavior Disorders
Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders
This study will evaluate the effectiveness of a parent training program in improving parenting skills and reducing behavioral symptoms in young children who are at risk for developing childhood behavior disorders.
- Trial name
- NCT00402857
- Testing
- Incredible Years Program
- Where
- 9 sites in United States
- Volunteers
- 345 people, healthy volunteers welcome
- Sponsor
- Tufts Medical Center
Neurofibromatosis Type 1
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with an estimated prevalence of 1/2190 to 1/6711. Attention deficit hyperactivity disorder (ADHD) has been reported to be common in NF1.
- Trial name
- NCT00169611
- Testing
- methylphenidate
- Where
- France
- Volunteers
- 80 people
- Sponsor
- Hospices Civils de Lyon
ADHD
Caregiver Stress, Mental Health, and Self-Efficacy in ADHD Households
Investigate the relationship between caregiver stress, mental health, and self-efficacy in families with children who have ADHD.
- Trial name
- Stress (NCT06994000)
- Where
- Saudi Arabia
- Volunteers
- 160 people
- Sponsor
- Alexandria University
ADHD - Attention Deficit Disorder With Hyperactivity
Effect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for Attention Deficit Hyperactivity Disorder (ADHD)
The proposed study is a double blind, randomized, placebo controlled study. The aim of the study is to evaluate the effect of nutritional formula supplementation on growth of prepubertal children treated with stimulants…
- Trial name
- NCT04962334
- Testing
- Nutritional supplementation standardized formula.
- Where
- Israel
- Volunteers
- 70 people
- Sponsor
- Rabin Medical Center
Attention-deficit Hyperactivity
Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)
Drug treatment is often the first and only line of treatment available for ADHD. However, some do not benefit from medication. The importance of psychotherapy is becoming more widely accepted.
- Trial name
- NCT04714866
- Testing
- Cognitive behavioral therapy for ADHD
- Where
- Iceland
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- University of Iceland
ADHD, Adolescence
Plan My Life Together; a Group Training for Adolescents With ADHD
This observational study is a first orientation on the effects and feasibility of a group training to plan and organize for adolescents with attention deficit disorder (ADHD).
- Trial name
- NCT05726812
- Testing
- Plan My Life Together
- Where
- Netherlands
- Volunteers
- 30 people
- Sponsor
- GGZ Noord-Holland-Noord
Attention Deficit Hyperactivity Disorder
An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder
A single arm, open-label, phase 3 multicenter study to evaluate the effectiveness and tolerability of atomoxetine (given once daily, target dose 1.2 mg/kg/day), as perceived by patients, parents and physicians, and its impact on…
- Trial name
- NCT00191737
- Testing
- Atomoxetine
- Where
- 2 sites in Germany
- Volunteers
- 147 people
- Sponsor
- Eli Lilly and Company
Insomnia, ADHD
CBT for Insomnia in Adolescents With ADHD
Insomnia and attention deficit hyperactivity disorder (ADHD) are highly comorbid conditions with an intricate, bidirectional relationship.
- Trial name
- NCT06351930
- Testing
- CBT-I + UC group
- Where
- 2 sites in Hong Kong
- Volunteers
- 84 people
- Sponsor
- The University of Hong Kong
Attention-Deficit/Hyperactivity Disorder
A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)
The purpose of the study is to evaluate the psychometric validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record.
- Trial name
- NCT00885807
- Where
- Canada
- Volunteers
- 220 people, healthy volunteers welcome
- Sponsor
- University of British Columbia
Attention Deficit Hyperactivity Disorder
A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)
ADHD is one of the most prevalent psychiatric conditions, consuming a large proportion of resources in psychiatric care, often accompanied by long waiting lists to receive proper assessment.
- Trial name
- NCT05588713
- Testing
- Brief assessment protocol, Comprehensive assessment protocol
- Where
- Sweden
- Volunteers
- 142 people
- Sponsor
- Uppsala University
Attention Deficit Disorder With Hyperactivity, Placebo Effect
Attention and Pain in Children With and Without Attention Deficit and/or Hyperactivity Disorder
In Quebec, there has been an important increase of Attention Deficit Hyperactivity Disorder (ADHD) diagnosis since 2015. ADHD symptoms, related to behavioural and/or concentration difficulties, are very similar to other disorders…
- Conditions
- Attention Deficit Disorder With Hyperactivity, Placebo Effect, Nocebo Effect, Pain
- Trial name
- ADE (NCT04766580)
- Where
- Canada
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Université de Sherbrooke
Children Aged 6-18 Years With the Diagnosis of ADHD
Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder
The overarching aim of the study is to assess the efficacy of Janssen's icon Application (App), a digital tool designed to improve adherence to medication treatment in children with ADHD. Our specific hypotheses are: 1.
- Trial name
- App ADHD (NCT06375525)
- Testing
- Janssen's icon Application (App)
- Where
- Israel
- Volunteers
- 39 people
- Sponsor
- Prof. Doron Gothelf MD
Neurodevelopmental Disorders, Autism Spectrum Disorder
Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery
In France, more than one in ten school-aged children suffers from a mental health disorder, and half of these disorders appear before the age of 14. Yet, only half of affected children receive appropriate support.
- Conditions
- Neurodevelopmental Disorders, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Atypical Neurodevelopmental Disorder
- Trial name
- COGSO (NCT07439276)
- Testing
- Test, Questionnaires
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
The purpose of this study is to test the intervention using a more rigorous randomized controlled trial design in order to demonstrate its efficacy compared to a wait-list control, thus ensuring that change in behavior does not…
- Trial name
- NCT01919073
- Testing
- Immediate Treatment Group, Delayed Treatment Group
- Where
- United States
- Volunteers
- 29 people
- Sponsor
- Baylor College of Medicine
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.